- Open Access
Antifungal activity of pomegranate peel extract and isolated compound punicalagin against dermatophytes
© Foss et al.; licensee BioMed Central Ltd. 2014
Received: 13 December 2013
Accepted: 13 July 2014
Published: 5 September 2014
Dermatophyte species infect the epidermis and appendages, often with serious social and health-economic consequences. The hydroalcoholic extract of pomegranate fruit peel showed activity against the dermatophyte fungi Trichophyton mentagrophytes, T. rubrum, Microsporum canis and M. gypseum.
Hydroalcoholic extract was prepared with pomegranate peels. This crude extract was fractionated and submitted to liquid-liquid partition, resulting in an active fraction which was fractionated in a Sephadex LH-20 column, followed by a Lobar column. The structure of the active compound was established with the use of spectroscopic methods.
The crude extract of pomegranate fruit peel showed activity against the dermatophytes Trichophyton mentagrophytes, T. rubrum, Microsporum canis, and M. gypseum, with MICs values of 125μg/ml and 250μg/ml, respectively for each genus. Punicalagin was isolated and identified by spectroscopic analysis. The crude extract and punicalagin showed activity against the conidial and hyphal stages of the fungi. The cytotoxicity assay showed selectivity for fungal cells than for mammalian cells.
These results indicated that the crude extract and punicalagin had a greater antifungal activity against T. rubrum, indicating that the pomegranate is a good target for study to obtain a new antidermatophyte medicine.
Dermatophytes are fungi that use keratin for their nutrition and may cause infections of the nails, skin, and hair, known as dermatophytosis. These organisms are classified into three genera: Epidermophyton, Trichophyton, and Microsporum. Although not life-threatening, superficial mycoses due to dermatophytes have been among the most common communicable diseases of humans since antiquity, and have considerable social and health-economic implications .
Generally, dermatophytes infect the superficial layers of skin. However, immunocompromised patients, such as AIDS patients or recipients of kidney transplants, can be affected by deep injury in the dermal layer, resulting in disseminated lesions that may take fatal forms -. Although many antifungals are available, their side effects and drug interactions, and the existence of resistant organisms have created a need to find safer and more effective treatments . Also, dermatophytosis treatments are, in general, expensive and must be applied over long periods.
Natural products have proven to be an alternative source of new active molecules. In many countries, mainly in developing countries, plants have been used as the primary basic health treatment. The pomegranate Punica granatum is a bush 3 to 5 meters in height, with opposite and obtuse leaves, flowers with wrinkled white, yellow, or orange petals. The fruit is composed of a yellow to red peel that covers the seeds, the fleshy arils of which are eaten. Punica granatum is a plant with worldwide application in folk medicine. There are references to an antimicrobial effect of pomegranate products against many pathogenic bacterial species, including inhibition of formation of biofilms -, antiplasmodial activity, and effects against Entamoeba histolytica and Giardia lamblia. Polyphenols extracted from pomegranate fruit rind were active against phytopathogenic fungi . The extract of P. granatum showed good results as a topical antifungal agent for the treatment of candidosis associated with denture stomatitis . The tannin punicalagin is the major component of pomegranate fruit peel. This substance was isolated not only from Punica granatum, but also was described from Terminallia mollis and Terminallia brachystemma, as having antifungal activity against Candida albicans, C. krusei, and C. parapsilosis.
The present study evaluate the antidermatophyte activity of pomegranate fruit peel extract and investigate its effect on different fungal development stages, cytotoxicity and possible mechanisms of action. The active substance of pomegranate peel was isolated and identified as well.
Plant material and crude extract
Punica granatum fruits were collected in December 2007 in Mariná; Paraá; Brazil. The peel was separated manually (2183.8g) and extracted with a 90% (v/v) hydroalcoholic solution, by maceration at room temperature for 5 days in a dark room. The hydroalcoholic extracts were filtered, evaporated under vacuum at 40°, lyophilized, and kept in a freezer at −10°. This crude extract was assayed against four species of dermatophyte fungi and Gram-positive and Gram-negative bacteria.
Isolation of the active substance
First, 200μl of an aqueous solution of the crude extract (20μ) was submitted to liquid-liquid partition, and eluted with ethyl acetate and then with n-butanol; this procedure was repeatead four times with each solvent, resulting in three fractions: F1 (water), F2 (ethyl acetate), and F3 (n- butanol). The collected fractions were evaporated under vacuum and lyophilized in the same conditions as for the extract. Second, 0.5μ of the fraction with the best activity (F1) was dissolved in water, filtered through cotton wool and then placed in a Sephadex LH-20 column. The procedure was performed twice to maximize the yield. It was monitored by thin-layer chromatography (TLC), mobile phase n- butanol: acetic acid: water (40:10:50), and observed as a natural yellow substance. Finally, after antifungal tests, the active subfraction was placed in a Lobar (C-18) column and eluted with methanol:water (1:1), also monitored by TLC. The structure of the active compound was established with the use of spectroscopic methods (EI-MS, 1H NMR, 13C NMR, H-H COSY, HMBC, HMQC, and DEPT). The isolated substance was tested against Trichophyton rubrum.
Microorganisms and growth conditions
Dermatophyte species used for this investigation were Microsporum canis ATCC 32903, Microsporum gypseum ATCC 14683, Trichophyton mentagrophytes ATCC 1481 and Trichophyton rubrum ATCC 28189. Gram-negative bacteria Pseudomonas aeruginosa ATCC 27853 and Escherichia coli ATCC 25922 and Gram-positive bacteria Bacillus subtilis ATCC 6623 and Staphylococcus aureus ATCC 25923 were also investigated, because secondary infections may occur in dermatophytoses.
Microdilution broth assay
Antifungal and antibacterial assays were performed by microdilution method in sterile flat-bottom microplates according to CLSI ,. Each well contained appropriate test samples, culture medium, and approximately 105 cells for bacteria, and 104 spores in a total volume of 100μl. The plates were incubated at 37° and 24 h for bacteria and 28° during 72 h for dermatophytes. The MIC (Minimal Inhibitory Concentration) was defined as the lowest concentration of a compound at which the microorganism tested did not demonstrate visible growth. To determine the minimal fungicidal effect, 10μl of suspension from the MIC was spotted in Sabouraud agar and incubated for 24 to 72 h at 28°. The minimum fungicidal concentration (MFC) was defined as the lowest concentration that yielded negative subcultures or only one colony.
Conidial germination inhibition assay
Different concentrations of test samples in 90μl were prepared in 96-well flat-bottom micro-culture plates by the double dilution method. The wells were prepared in duplicate for each concentration. An inoculum of 10μl of spore suspension containing 2000-3000 spores was added to each well. Plates were incubated at 28° for 24 h and then examined for spore germination under an inverted microscope. For analysis, spores were considered germinated if they had a germ tube at least twice the length of the spore.
Disc diffusion method
Disc diffusion method and fluorescence microscopy were used to evaluate the hyphal growth inhibition. Plates with Sabouraud Dextrose Agar were centrally inoculated with T. rubrum and incubated at 28° for 3-5 days. Test discs were made with the extract, punicalagin, and Nystatin, with concentrations close to the MIC. These discs and one control disc (with 10μl of sterile water) were arranged around the colony on the plate, at a distance of 0.5°m, and incubated at 28° for 72 h. The hyphal growth inhibition was evaluated visually and photographed .
Sub-inhibitory concentrations of the crude extract in 500μl of culture medium were prepared by the double-dilution method, in 24-well flat-bottom micro-culture plates, on which round cover slips were placed. The wells were prepared in duplicate for each concentration. The wells were inoculated with 50μl of spore suspension, containing 10,000-15,000 spores. The plates were incubated at 28° for 24 h. Then, the cover slips carefully removed were and washed in PBS, pH7.2, with light manual shaking. Next, the medium was carefully removed and cover slips with adhered cells were stained with Calcofluor White M2R (Sigma, St. Louis, MO, USA) and mounted on a slide with synthetic resin (Araldite 502). Slides were viewed by means of a Zeiss fluorescent microscope .
Confluent Vero cell monolayers grown in 96-well cell-culture plates were incubated with a tenfold serial dilution of punicalagin, starting with a concentration of 1000μg/ml - for 48 h at 37° and 5% CO2. At that time, cultures fixed with 10% trichloroacetic acid for 1 h at 4° were stained for 30μin with 0.4% sulforhodamine B (SRB) in 1% acetic acid and subsequently washed with distilled water. Bound SRB was solubilized with 150μl 10μM Tris-base solution. Absorbance was read in an ELISA plate reader at 530 nm. The cytotoxicity was expressed as a percentage of the optical density compared to the control.
Results and discussion
Isolation of active substance
From 2183.8μ of pomegranate fruit peel, 220.6μ of crude extract was obtained, a yield of 10.1%. Pomegranate fruit peel is rich in tannins, high-molecular-weight plant polyphenols, which can be classified into two chemically and biologically distinct groups: condensed tannin and hydrolyzable tannin, the latter composed of phenolic acids and glycosyl esters. Hydrolyzable tannins are separated into ellagitannins (containing ellagic acid) and gallotannins (containing gallic acid) . The structure of active compound, punicalagin, obtained by successive bioactive-guided steps, was established by spectroscopic methods (EI-MS, 1H NMR, 13C NMR, H-H COSY, HMBC, HMQC, and DEPT). Punicalagin has been isolated from plants  by different methods. However, some of the isolation techniques, such as high-speed countercurrent chromatography, require expensive apparatus . The present method is a less expensive alternative to obtain punicalagin with excellent results, and resembles a purification procedure reported . The spectral analysis was compared with that reported by Doig et al. , which confirmed the isolated substance as punicalagin. The mass spectrum (EI-MS) of the punicalagin isolated confirmed to that reported by Seeram et al. . Punicalagin anomers can be observed in the mass spectrum, which show double chemical shifts at the same carbon or hydrogen.
Punicalagin FAB-MS at m/z 1083.4 found C48H28O30. The 13C NMR results: − 88.78 (C-1), 69.73 (C-2), 75.33 (C-3), 73.13 (C-4), 65.38 (C-5), 63.23 (C-6), 168.26 (C-7), 124.59 (C-8), 105.61/108.71 (C-9), 144.72 (C-10), 135.67 (C-11), 144.72 (C-12), 114.42 (C-13), 113.87 (C-14), 144.62 (C-15), 135.5 (C-16), 144.4 (C-17), 105.02/108.71 (C-18), 124.24 (C-19),168.45/148.57 (C-20), 167.6 (C-21), 123.57 (C-22), 109.51 (C-23), 144.39 (C-24), 137.76 (C-25), 144.39 (C-26), 117.7 (C-27), 109.51 (C-28), 147.35 (C-29), 136.86 (C-30), 135.5 (C-31),112/113.37 (C-32), 121.75/121.87 (C-33), 157.81 (C-34), 112.56/113.37 (C-35), 135.18 (C-36),136.86/139.2 (C-37), 147.35 (C-38), 109.51 (C-39), 121.75/121.87 (C-40), 157.3 (C-41),113.87 (C-42), 144.36 (C-43), 134.88 (C-44), 144.11 (C-45), 105.02/108.71 (C-46), 124.59 (C-47), 168.20 (C-48). HMBC1H-13C and 1H results: 5.06/5.13 (H-C1, m), 4.65/4.71 (H-C2, m),5.06/5.13 (H-C3, m), 4.65/4.71 (H-C4, m), 3.09/3.17 (H-C5, m), 4.03 (H−-C6, m), 1.83 (H−-C6,d), 6.39/6.41 (H-C9, s), 6.28/6.41 (H-C18, s), 6.7 (H-C23, s), 6.28/6.41 (H-C46, s).
Minimal inhibitory concentration (MIC)
Antifungal activity (−g/ml) against Trichophyton rubrum
Antifungal activity (−g/ml) against Trichophyton rubrum
Under certain conditions, dermatophytosis can be complicated by secondary bacterial infections. Therefore, we investigated whether the hydroalcoholic extract exerts, in addition to its antifungal effects, a significant antibacterial activity against Gram-negative and Gram-positive bacteria. The crude extract from pomegranate showed good activity on S. aureus, B. subtilis and P. aeruginosa with MICs of 62.5, 62.5 and 250μg/ml. E. coli MIC >1000μg/ml were considered resistant (Table1).
There are two phases of fungal growth, conidial germination and hyphal growth, in which drug action can occur. Conidial germination inhibition occurred at concentration of 62.5μg/ml for both crude extract and punicalagin. Nystatin was able to inhibit conidial germination at 0.39μg/ml. This is particularly noteworthy because the MICs of crude extract and fraction extract were found to be 125μg/ml. This similar effect of the extract and isolated substance is due to the fact that punicalagin is the majority substance in the pomegranate fruit peel .
Cytotoxicity was monitored using SRB assays. Cell viability after exposure to 100μg/ml of crude extract, fraction P1, and punicalagin was 83%, 99%, and 90%, respectively (data not shown). The concentration of punicalagin with 50% cytotoxicity (CC50 value) on Vero cell was 400μg/ml, showing that punicalagin is 6.4 times more selective for fungi cells than for mammal cells, indicating that the crude extract may be ideal for use in topical form. The values of CC50 of punicalagin are similar to those that have been reported, with CC50 as 460μg/ml . The acute toxicity evaluated, in vivo, using Wistar rats with intranasal administration, and detected that the LD50 (the dose that can kill 50% of the assayed animals) was 731μg/ml . Pomegranate juice may contain 2μ/L of punicalagin. Sprague Dawley rats fed a diet containing 6% punicalagin, for 37 days, showed no toxicity . These data support the initial idea of a treatment with crude extract of pomegranate fruit peel in the topical form.
Pomegranate extract inhibited the growth of T. rubrum, T. mentagrophytes, M. canis and M. gypseum. Spectroscopic analyses revealed punicalagin as the active substance. The antidermatophyte assay, using Trichophyton rubrum as a model, showed that the crude extract acts on conidial and hyphal structures. Also, cytotoxicity assay showed that punicalagin was more selective for fungal than mammal cells, indicating its probable best use in clinical applications. These results indicated that the crude extract and punicalagin had a greater antifungal activity against T. rubrum, indicating that pomegranate is a good target for study due to its potential future use as a new therapeutic alternative against dermatophytosis.
SRF carried out the phytochemical and microbiological studies and drafted the manuscript. CVN and TUN participated in microscopy and cytotoxicity assays. DAGC participated in spectroscopic assays. EHE participated with microbiological assays and draft the manuscript. BPDF conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
This study was supported by Conselho Nacional de Desenvolvimento Cient fico e Tecnolμico (CNPq), Capacitao e Aperfeioamento de Pessoal de ável Superior, (Capes), Fundao Araucria, and Programa de Ps-graduao em Cincias Farmacuticas da Universidade Estadual de Mariná. Part of the experiments were carried out at the Complexo de Central de Apoio a Pesquisa (COMCAP) MCT/FINEP/UEM.
- Rinaldi MG: Dermatophytosis: Epidemiological and microbiological update. J Am Acad Dermatol. 2000, 43: 120-124. 10.1067/mjd.2000.110378.View ArticleGoogle Scholar
- Johnson L: Dermatophytes- the skin eaters. Mycologist. 2003, 17: 147-149. 10.1017/S0269915X04004185.View ArticleGoogle Scholar
- Tsang P, Jimenez-Lucho V: Deep dermatophytosis caused by Trichophyton rubrum in a patient with AIDS. J Am Acad Dermatol. 1996, 34: 1090-1091. 10.1016/S0190-9622(96)90298-4PubMedView ArticleGoogle Scholar
- Sekin D, Haberal M: Deep dermatophytosis caused by Trichophyton rubrum with concomitant disseminated nocardiosis in a renal transplant recipient. J Am Acad Dermatol. 2004, 51: 173-176. 10.1016/j.jaad.2004.05.008.View ArticleGoogle Scholar
- Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E: Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect. 2004, 10: 48-66. 10.1111/j.1470-9465.2004.00839.xPubMedView ArticleGoogle Scholar
- Pelegrini A, Takahashi JP, Pereira CQM, Pessoni RB, Souza MC: Incidence of dermatophytosis in a public hospital of So Bernardo do Campo, So Paulo State, Brazil. Ver Iberoam Micol. 2009, 26: 118-120. 10.1016/S1130-1406(09)70022-1.View ArticleGoogle Scholar
- Straten MRV, Hossain MA, Ghannoum MA: Cutaneous infections Dermatophytosis, onychomycosis and Tinea versicolor. Infect Dis Clin North Am. 2003, 17: 87-112. 10.1016/S0891-5520(02)00065-X.View ArticleGoogle Scholar
- Melndrez PA, Capriles VA: Antibacterial properties of tropical plants from Puerto Rico. Phytomedicine. 2006, 13: 272-276. 10.1016/j.phymed.2004.11.009.View ArticleGoogle Scholar
- Al-Zoreky NS: Antimicrobial activity of pomegranate (Punica granatum L.) fruit. Int J Food Microbiol. 2009, 134: 244-248. 10.1016/j.ijfoodmicro.2009.07.002PubMedView ArticleGoogle Scholar
- DellAgli M, Galli GV, Corbett Y, Taramelli D, Lucantoni L, Habluetzel A, Maschi O, Caruso D, Giavarini F, Romeo S, Bhattacharia D, Bosisio E: Antiplasmodial activity of Punica granatum L. fruit rind. J Ethnopharmacol. 2009, 125: 279-285. 10.1016/j.jep.2009.06.025View ArticleGoogle Scholar
- Bakkiyaraj D, Nandhini JR, Malathy B, Pandian SK: The antibiofilm potential of pomegranate (Punica granatum L.) extract against human bacterial and fungal pathogens. Biofouling. 2013, 29: 929-937. 10.1080/08927014.2013.820825PubMedView ArticleGoogle Scholar
- Calzada F, Ypez-Mulia L, Aguilar A: In vi tro susceptibility of Entamoeba histolytica and Giardia lamblia to plants used in Mexican tradicional medicine for the treatment of gastrointestinal disorders. J Ethnopharmacol. 2006, 108: 367-370. 10.1016/j.jep.2006.05.025PubMedView ArticleGoogle Scholar
- Osorio E, Flores M, Herández D, Ventura J, Rodrμuez R, Aguilar CN: Biological Efficiency of polyphenolic extracts from pecan nuts Shell (Carya illionensis), pomegranate husk (Punica granatum) and creosote bush leaves (Iarrea tridentate Cov.) against plant pathogenic fungi. Ind Crops Prod. 2010, 31: 153-157. 10.1016/j.indcrop.2009.09.017.View ArticleGoogle Scholar
- Vasconcelos LCS, Sampaio MCC, Sampaio FC, Higino JS: Use of Punica granatum as an antifungal agent against candidosis associated with denture stomatitis. Mycoses. 2003, 46: 192-196. 10.1046/j.1439-0507.2003.00884.xPubMedView ArticleGoogle Scholar
- Liu M, Katerere DR, Gray AI, Seidel V: Phytochemical and antifungal studies on Terminalia mollis and Terminalia brachystemma. Fitoterapia. 2009, 80: 369-373. 10.1016/j.fitote.2009.05.006PubMedView ArticleGoogle Scholar
- Reference Method for Broth Dilution Antifungals Susceptibility Testing of Conidium-Forming Filamentous Fungi: Approved Standard, M38-A2. 2008, CLSI, WayneGoogle Scholar
- Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. Approved Standard, M07-A9. 2012, CLSI, WayneGoogle Scholar
- Prasad NR, Anandi C, Balasubramanian S, Pegalendi KV: Antidermatophyte activity of extracts from Psoralea coryfolia (Fabaceae) correlated with the presence of a flavonoid compound. J Ethnopharmacol. 2001, 91: 21-24. 10.1016/j.jep.2003.11.010.View ArticleGoogle Scholar
- Koroishi AM, Foss SR, Cortez DAG, Ueda-Nakamura T, Nakamura CV, Dias Filho BP:In vitro antifungal activity of extracts and neolignans from Piper regnelli against dermatophytes. J Ethnopharmacol. 2008, 117: 270-277. 10.1016/j.jep.2008.01.039PubMedView ArticleGoogle Scholar
- Cunha AP, Silva AP, Roque OR, Cunha E: Plantas e produtos vegetais em cosmtica e dermatologia. 2004, Editora Fundao Caloustre Gulbenkian, LisboaGoogle Scholar
- Kulkarni AP, Mahal HS, Kapoor S, Aradhya SM:In vitro studies on the binding, antioxidant, and cytotoxic actions of Punicalagin. J Agric Food Chem. 2007, 55: 1491-1500. 10.1021/jf0626720PubMedView ArticleGoogle Scholar
- Lu J, Wei Y, Yuan Q: Preparative separation of punicalagin from pomegranate husk by high-speed countercurrent chromatography. J Chromatogr B. 2007, 857: 175-179. 10.1016/j.jchromb.2007.06.038.View ArticleGoogle Scholar
- Seeram N, Lee R, Hardy M, Heber D: Rapid large scale purification of ellagitannins from pomegranate husk, a by-product of the commercial juice industry. Sep Purif Technol. 2005, 41: 49-55. 10.1016/j.seppur.2004.04.003.View ArticleGoogle Scholar
- Doig AJ, Williams DH, Oelrichs PB, Baczynsky JL: Isolation and structure elucidation of punicalagin, a toxic hydrolysable tannin, from Terminalia oblonga. J Chem Soc Perkin Trans. 1990, 673: 2317-2321. 10.1039/p19900002317.View ArticleGoogle Scholar
- Aljabre SHM, Randhawa MA, Akhtar N, Alakloby OM, Algurashi AM, Aldossary A: Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. J Ethnopharmacol. 2005, 101: 116-119. 10.1016/j.jep.2005.04.002PubMedView ArticleGoogle Scholar
- Svetaz L, Zuljan F, Derita M: Value of the ethnomedical information for the discovery of plants with antifungal properties. A survey among seven Latin American countries. J Ethnopharmacol. 2010, 127: 137-158. 10.1016/j.jep.2009.09.034PubMedView ArticleGoogle Scholar
- Vidal A, Fallarero A, Pea BR, Medina ME, Gra B, Rivera F, Gutierrez Y, Vuorela PM: Studies on t toxicity of Punica granatum L. (punicaceae) whole fruit extracts. J Ethnopharmacol. 2003, 89: 295-300. 10.1016/j.jep.2003.09.001PubMedView ArticleGoogle Scholar
- Cerda B, Cern JJ, Toms-Barber T, Espn JC: Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Food Chem. 2003, 51: 3493-3501. 10.1021/jf020842cPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.